References

  1. Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord.1991; 1(1):19-29. PubMed | Google Scholar

  2. Bushby K , Bourkeb J, Bullockc R, Eaglea M, Gibsond M, Quinbyd J. The multidisciplinary management of Duchenne muscular dystrophy. Curr Paediatri. 2005;15(4): 292-300. PubMed | Google Scholar

  3. Sarnat HB. Neuromuscular disorders. Nelson Textbook of Paediatrics-19th edition.2011. Philadelphia. Elsevier Saunders. Google Scholar

  4. Bushby KM, Hill A, Steele JG. Failure of early diagnosis in symptomatic Duchenne muscular dystrophy. Lancet. 1999; 353(9152): 55-78. PubMed | Google Scholar

  5. Manzur AY, Kinali M, Muntoni F. Update on the management of Duchenne muscular dystrophy. Arch Dis Child. 2008; 93(11):986-90. PubMed | Google Scholar

  6. Kinali M, Manzur AY, Muntoni F. Recent developments in the management of Duchenne muscular dystrophy. Paediatri Child Health. 2008; 18(1): 22-26. PubMed | Google Scholar

  7. Specht LA, Beggs AH, Korf B, Kunkel LM, Shapiro F. Prediction of dystrophin phenotype by DNA analysis in Duchenne/Becker muscular dystrophy. Pediatr Neurol.1992; 8(6):432-6. PubMed | Google Scholar

  8. Yiu EM, Kornberg AJ. Duchenne muscular dystrophy. Neurol India. 2008; 56(3):236-47. PubMed | Google Scholar

  9. Weidner NJ. Developing an interdisciplinary palliative plan for the patient with Muscular Dystrophy. Paediatr Ann. 2005; 34(7):546-52. PubMed | Google Scholar

  10. Essex C, Roper H. Late diagnosis of Duchenne's muscular dystrophy presenting as global developmental delay. BMJ. 2001;323(7303):37-8. PubMed | Google Scholar